SCINTIMUN® 1 mg

Kit for Labelling Monoclonal Antibody (MAb) BW 250/183 with Technetium (99mTc)

Isotope Technetium (99mTc)
Number of labelling sets 1 or 2
Each vial 1 contains 5.02 mg dry substance :
  • Besilesomab
  • Disodium hydrogen phosphate, anhydrous
  • Sodium dihydrogen phosphate, anhydrous
  • Under nitrogen atmosphere
  • Sorbitol E420
Each vial 2 contains 3 mg dry substance :
  • 1,1,3,3-propane tetraphosphonic acid, tetrasodium salt, dihydrate (PTP)
  • Tin (II) chloride dihydrate
  • Sodium hydroxyde 1N
  • (pH adjustment)
  • Hydrochloric acid 1N
  • (pH adjustment)
  • Under nitrogen atmosphere


1 mg








2.7 mg
Volume of pertechnetate 99mTc to use for reconstitution 2 to 7 mL
Radiochemical purity ≥ 95 %
Storage 2 years at 2 - 8°C
Stability of labelled product 3 h not above 25°C
Protected from light
Activity per vial 400 to 1800 MBq
Indications / Posology Determination of the location of inflammation/infection
periphal bone in adults with suspected osteomyelitis
(400-800 MBq). Should not be used for the diagnosis of
diabetic foot infection
Time between injection and examination 3 to 6 h and late image 24 h
Availability From stock

Availability of the product in your country according to the registration status.

Support Solution

IBA does not provide pharmaceuticals... we do much more than that. Beyond the quality of our products and services you expect a leading radiopharmaceutical company to provide you with all the environment necessary to master our products and to operate your daily activity in a professional manner.

Our set of customer solutions includes :

  • Product trainings
  • Round tables facilitation
  • Patient recruitment support
  • ISS (Investigator Sponsored Studies)
  • Organisations of symposiums
  • Newsletters

You are here : HomeProducts › SCINTIMUN Granulocyte

We Protect, Enhance, and Save lives © IBA 2012 | All rights reserved | Site map | made by Globule Bleu